SynthesisFrontiers in cardiovascular medicine2026
GLP-1-Based therapies for obesity-related heart failure with preserved ejection fraction: an umbrella review incorporating broader heart failure and cardiometabolic evidence.
Qiang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.